Amgen Inc (NAS:AMGN)
$ 308.45 -1.7 (-0.55%) Market Cap: 165.46 Bil Enterprise Value: 220.69 Bil PE Ratio: 44.06 PB Ratio: 32.95 GF Score: 89/100

Amgen Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 04:20PM GMT
Release Date Price: $240.64 (-0.03%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Welcome to the second day of the Bank of America Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here. And we are thrilled to have with us on stage, Amgen. And speaking on behalf of Amgen, we have Peter Griffith, CFO; and Rob Lenz, Senior Vice President, Global Development. Welcome, guys.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Great to be here.

Rob Lenz
Amgen Inc. - SVP of Global Development

Great to be here.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Thank you so much to Bank of America, BofA, for inviting us.

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Great to do the meeting in person, too, right?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot